Fibrocell Science

Latest Headlines

Latest Headlines

Billionaire Kirk orchestrates $45M cell therapy tie-up in biotech deal spree

Biotech billionaire RJ Kirk has hitched another therapeutic developer to his synthetic biology wagon at Intrexon. This time it's Fibrocell Science, an Exton, PA-based developer with a personalized cell therapy for "aesthetic dermatology" on the market.

Fibrocell captures FDA approval for personalized wrinkle treatment

Fibrocell Science ($FCSC) has won FDA approval to market a new competitor to Botox which uses a sample of a person's cells to create an individualized therapy to smooth out the wrinkles-often called